Silver shield for tiniest tots: new dressing may stop deadly infections
NCT ID NCT00964093
First seen Mar 26, 2026 · Last updated May 24, 2026 · Updated 10 times
Summary
This study tested whether a silver alginate dressing (Algidex) can prevent central line infections in very low birth weight infants (500-1500 grams). One hundred babies in the NICU with central lines were randomly assigned to receive either the silver dressing or standard care. The goal was to see if the dressing reduces infections, while also checking safety and hospital stay length.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CENTRAL LINE BLOODSTREAM INFECTIONS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Baylor University Medical Center - Women and Children's Services
Dallas, Texas, 75204, United States
Conditions
Explore the condition pages connected to this study.